STEPHY.T.P, SREEJITH. K, and Dr. BINDU G. 2017. “Comparison of Quality of Life (QOL) for Patients With Breast Cancer Receiving Adjuvant Tac (docetaxel, Doxorubicin, Cyclophosphamide) and Fac (5-Fluorouracil, Doxorubicin, Cyclophosphamide) Therapy”. International Journal of Pharma and Bio Sciences 8 (3):373-82. https://doi.org/10.22376/ijpbs.2017.8.3.p373-382.